• SENSEX 78,079.96
    113.61 (+0.15%)
  • BANKNIFTY 57,635.25
    -250.60 (--0.43%)
  • UltraTech Cem.
    11,575.00 10,329.00(%)
  • JSW Energy
    562.05 617.30(%)
  • Urban Company
    146.00 201.00(%)
  • HDFC Bank
    724.45 722.00(%)
  • ICICI Bank
    1,406.60 1,187.55(%)
  • Reliance Industries
    1,307.10 1,250.55(%)
  • Larsen & Toubro
    4,070.00 4,440.00(%)
  • Bharti Airtel
    1,970.05 2,174.70(%)
  • Godrej Consumer
    938.90 1,308.40(%)
  • Netweb Technol.
    5,200.00 5,241.65(%)
  • Thyrocare Tech.
    594.30 342.55(%)
  • Fortis Health.
    904.95 1,105.00(%)
  • SBI
    1,073.20 798.60(%)
  • Astral
    1,599.00 1,767.95(%)
  • M & M
    3,440.00 3,840.00(%)
  • ITC
    279.50 426.50(%)
  • Cupid
    295.00 295.00(%)
  • Bajaj Finserv
    2,037.00 2,194.65(%)
  • Axis Bank
    1,215.30 1,041.30(%)
  • Solar Industries
    20,400.00 20,400.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Marksans Pharma Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 3285.0
  • ISIN : INE750C01026
303.40 -9 (-2.94%)
  • As on 13 Aug 2026 (EOD)

  • Today’s Low

    301.90

  • Today’s High

    319.40

  • Open

    313.00

  • Perv Close

    312.60

  • 52W Low

    155.00

  • 52W High

    320.00

Key Indicators

  • P/E(TTM)

    42.70

  • Mar.Cap (₹Cr.)

    13,748.99

  • Div & Yield %

    0.30

  • Book Value(₹)

    36.46

  • Debt-Equity Ratio

    -2.94

  • AGM Date

    13-Aug-2026

  • EPS

    7.10

  • P/E Ratio

    42.70

Financials Ratios

  • Debt-Equity Ratio

    0.10

  • Mar.Cap (₹Cr.)

    13,748.99

  • RONW (%)

    16.53

  • ROCE (%)

    20.78

Score Board

  • Equity (₹ in Cr.)

    45.32

  • BV (₹)

    36.50

  • Sales( ₹ in Cr.)

    1,341.48

  • NP (in Cr.)

    299.27

  • NP Var(%)

    60.0

  • Div%

    90.0

  • CPS (₹)

    7.40

  • EPS (₹)

    6.60

  • Traded Value (₹ in Lakhs)

    14,172.70

  • 52 Week High

    320.00

  • 52 Week Low

    155.00

  • Price BSE

    313.0

  • Price NSE

    313.00

  • Market Capital( in Cr.)

    14,172.70

  • P/C Ratio

    42.50

  • P/E Ratio

    47.40

  • Price Vs.BV

    6.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 1,341.48 1,174.37 853.27 655.20 658.29 599.55
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,341.48 1,174.37 853.27 655.20 658.29 599.55
Other Income 103.53 65.79 62.07 60.48 42.25 31.16
Stock Adjustments -3.30 -0.70 7.25 10.19 -3.89 -0.55
Total Income 1,441.71 1,239.46 922.59 725.87 696.65 630.16
EXPENDITURE :            
Raw Materials 675.49 639.24 486.18 404.64 373.70 337.36
Power and Fuel Cost 32.95 30.73 26.04 14.24 11.49 10.90
Employee Cost 121.98 101.68 77.19 56.09 60.46 54.64
Other Manufacturing Expenses 65.94 64.62 46.10 21.09 5.25 6.98
Selling and Administration Expenses 96.71 112.99 73.19 61.54 67.57 60.08
Miscellaneous Expenses 21.55 16.32 11.88 15.89 22.22 15.31
Employee Benefit Expenses 121.98 101.68 77.19 56.09 60.46 54.64
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,014.62 965.58 720.58 573.49 540.68 485.28
Operating Profit 427.10 273.88 202.01 152.38 155.97 144.87
Interest 1.33 1.17 0.99 3.61 3.80 5.35
Gross Profit 425.77 272.71 201.02 148.77 152.17 139.52
Depreciation 34.23 29.45 29.13 16.74 17.66 15.19
Profit Before Tax 391.54 243.26 171.89 132.03 134.51 124.33
Current Tax 86.29 52.14 37.46 29.34 30.02 28.19
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 4.55 2.84 0.68 -0.17 0.50 -2.24
Reported Net Profit 300.70 188.27 133.76 102.87 103.99 98.38
Extraordinary Items 1.43 0.81 0.07 -0.05 0.00 0.03
Adjusted Net Profit 299.27 187.46 133.69 102.92 103.99 98.35
Adjustment below Net Profit 1.04 -0.30 0.28 -8.64 0.05 -0.20
P & L Balance brought forward 505.78 345.00 233.61 155.21 61.41 -32.69
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 36.25 27.19 22.66 15.82 10.23 4.09
P & L Balance carried down 771.26 505.78 345.00 233.61 155.21 61.41
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 90.00 80.00 60.00 50.00 25.00 25.00
Dividend Per Share(Rs) 0.90 0.80 0.60 0.50 0.25 0.25
Earnings Per Share-Unit Curr 6.64 4.15 2.95 2.27 2.54 2.40
Earnings Per Share(Adj)-Unit Curr 6.64 4.15 2.95 2.27 2.54 2.40
Book Value 36.46 30.53 26.98 24.52 16.90 14.65
Book Value(Adj)-Unit Curr 36.46 30.53 26.98 24.52 16.90 14.65

Shareholding Pattern

  • Promoter Group

    43.87%

  • Public Share Holding

    56.13%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 198,822,009 43.87 198,822,009 2
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 198,822,009 43.87 198,822,009 2
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 39,050,881 8.62 39,050,881 1
Financial Institutions / Banks 2,911 0.00 911 3
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 40,107,349 8.85 40,107,349 129
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 19,777,591 4.36 19,777,591 11
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 8,271,400 1.83 8,271,400 18
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 107,210,132 23.66 107,208,132 162
2] Non Institution
Bodies Corporate 8,125,414 1.79 8,124,414 1,038
Clearing Members 150,524 0.03 150,524 38
Directors of their Relatives 0 0.00 0 0
Employees 2,491 0.00 2,491 8
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 6,954,411 1.53 6,954,411 4,848
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 3,606,557 0.80 3,606,557 2,856
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 16,861,017 3.72 16,861,017 29
Individuals holding nominal share capital up to Rs. 1 lakh 110,262,491 24.33 110,043,681 237,640
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 301,594 0.07 301,594 10
Others 859,434 0.19 859,434 1
Sub Total 147,131,605 32.47 146,911,795 246,471
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 453,163,746 100.00 452,941,936 246,635

Company Background

Marksans Pharma LtdPharmaceuticals - Indian - Formulations

  • Marksans Pharma Ltd
  • BSE Code : 3285.0
  • ISIN : INE750C01026

  • Incorporation Year

    1992

  • Registered Office

    11th Flr GRANDEUR Oshiwara
    Veera Desai Extn Rd Andheri(W), Mumbai,
    Maharashtra-400053

  • Telephone

    91-22-40012000

  • FAX

    91-22-40012011

  • Chairman

    Mark Saldanha

  • Managing Director

    Mark Saldanha

  • Company Secretary

    Harshavardhan Panigrahi

  • Auditor

    MSKA & Associates

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No S6-2,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Marksans Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Marksans Pharma 303.20 1,445.01 1,341.48 42.70 25.59
Abbott India 27,617.45 7,217.19 6,929.05 37.81 43.78
Astrazeneca Phar 7,791.60 2,304.07 2,275.58 114.84 27.86
P & G Health Ltd 5,922.40 944.52 934.17 27.55 71.75
Glaxosmi. Pharma 2,664.65 3,932.76 3,790.20 42.57 58.17
Cipla 1,461.00 20,102.60 18,979.95 38.40 13.88
Bliss GVS Pharma 512.60 773.53 729.81 56.21 12.51
Amrutanjan Healt 491.85 469.50 451.82 26.34 21.89
Fermenta Biotec. 459.55 474.15 450.25 21.45 18.77
Guj. Themis Bio. 347.45 152.47 150.80 77.73 27.21
Ambalal Sarabhai 41.28 19.52 3.94 28.87 6.77